Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Partners with U Penn Team to Identify Molecular Signatures for Gene Doping

NEW YORK (GenomeWeb News) – Qiagen said today that it is partnering with researchers from the University of Pennsylvania to develop molecular tests to detect gene doping in athletes.
In the project, supported by the World Anti-Doping Agency and Qiagen, the U Penn team plans to climb Mount Everest with live mice. The researchers plan to use tissue and blood samples from these mice to identify a molecular signature for altitude-induced hypoxia, or oxygen deficiency.
Hypoxia stimulates the creation of erythropoietin, which promotes the production of red blood cells and is a commonly abused doping agent. While current tests fo doping can detect artificial EPO, it is very difficult to determine whether athletes have used genetic manipulation to produce more natural EPO, Qiagen said.  
The company said that the scientists plan to develop new tests for gene doping by comparing the “natural” molecular signatures obtained from the mice exposed to high altitudes with “induced” signatures created by gene doping.
"From a research point of view, a major challenge of this endeavor will be the extraction of samples from the mice under these extreme conditions," said Gabriel Willmann, an investigator on the project, in a statement. He said that the team will use Qiagen’s tools to collect, process, and analyze the samples.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.